Compare commits
10 commits
8cc85511d5
...
8b59d10930
| Author | SHA1 | Date | |
|---|---|---|---|
|
|
8b59d10930 | ||
| 95393c2327 | |||
|
|
4f2540e599 | ||
|
|
c51a401521 | ||
| 5d95f7ea1d | |||
|
|
fffc4dca43 | ||
| 03647c9809 | |||
|
|
d242d130ce | ||
| a4bc19a175 | |||
|
|
bce9f46fc3 |
12 changed files with 200 additions and 7 deletions
|
|
@ -33,6 +33,12 @@ The academic framing is significant: top-tier musicology journals treating conce
|
|||
|
||||
SCP Foundation with 9,800+ objects and 6,300+ tales demonstrates that protocol-distributed authorship (standardized format + peer review + voting) produces coherent worldbuilding at massive scale without centralized editorial authority. The emergent canonical clusters form organically through community consensus rather than top-down coordination. This confirms that worldbuilding can scale through structural constraints rather than editorial control, though it does NOT produce linear narrative (which requires concentrated authority per the tradeoff claim).
|
||||
|
||||
|
||||
### Additional Evidence (challenge)
|
||||
*Source: [[2015-00-00-cooper-star-trek-communicator-cell-phone-myth-disconfirmation]] | Added: 2026-03-18*
|
||||
|
||||
Martin Cooper, inventor of the first handheld cellular phone, directly contradicts the Star Trek communicator origin story. Motorola began developing handheld cellular technology in the late 1950s, several years before Star Trek premiered in 1966. Cooper stated he had been 'working at Motorola for years before Star Trek came out' and 'they had been thinking about hand held cell phones for many years before Star Trek came out.' Cooper later clarified that when he appeared to endorse the Star Trek connection in the documentary 'How William Shatner Changed the World,' he 'was just so overwhelmed by the movie' and conceded to something 'he did not actually believe to be true.' The technology predated the fiction, making causal influence impossible. The flip phone design (1996) did mirror the communicator's form factor, but this is design influence decades after the core technology existed, not causal commissioning of the technology itself.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -85,10 +85,16 @@ BALANCE Model's dual payment mechanism (capitation adjustment + reinsurance) plu
|
|||
|
||||
|
||||
### Additional Evidence (challenge)
|
||||
*Source: [[2025-12-01-who-glp1-guidelines-behavioral-therapy-combination]] | Added: 2026-03-18*
|
||||
*Source: 2025-12-01-who-glp1-guidelines-behavioral-therapy-combination | Added: 2026-03-18*
|
||||
|
||||
WHO's conditional recommendation structure and behavioral therapy requirement suggest the 'chronic use model' framing may be incomplete. The guideline establishes medication-plus-behavioral-therapy as the standard, not medication alone, which may have different economics than the pure pharmaceutical model. WHO also announced it will develop 'an evidence-based prioritization framework to identify which adults with obesity should be prioritized for GLP-1 treatment'—implying targeted use rather than universal chronic treatment.
|
||||
|
||||
|
||||
### Additional Evidence (challenge)
|
||||
*Source: [[2026-03-01-glp1-lifestyle-modification-efficacy-combined-approach]] | Added: 2026-03-18*
|
||||
|
||||
If GLP-1 + exercise produces durable weight maintenance (3.5 kg regain vs 8.7 kg for medication alone), then the chronic use assumption may be wrong. Patients who establish exercise habits during a 1-2 year medication window may not need indefinite treatment, fundamentally changing the cost trajectory. The inflationary projection assumes continuous medication; the combination data suggests a time-limited intervention model may be viable.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -73,10 +73,16 @@ BALANCE Model's manufacturer-funded lifestyle support requirement directly addre
|
|||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-12-01-who-glp1-guidelines-behavioral-therapy-combination]] | Added: 2026-03-18*
|
||||
*Source: 2025-12-01-who-glp1-guidelines-behavioral-therapy-combination | Added: 2026-03-18*
|
||||
|
||||
WHO's conditional recommendation requiring behavioral therapy combination provides international regulatory support for adherence interventions. The guideline explicitly states GLP-1s should be 'combined with intensive behavioral therapy to maximize and sustain benefits'—directly addressing the persistence problem by making behavioral support the standard of care rather than an optional add-on.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2026-03-01-glp1-lifestyle-modification-efficacy-combined-approach]] | Added: 2026-03-18*
|
||||
|
||||
Weight regain data shows that even among patients who complete treatment, GLP-1 alone produces 8.7 kg regain (vs 7.6 kg placebo) while GLP-1 + exercise produces only 3.5 kg regain. This means low persistence may be economically rational for patients if the medication alone doesn't create lasting value—the 15% two-year persistence rate may reflect patients discovering that medication without lifestyle change produces temporary results.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -0,0 +1,24 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "fiction-to-reality-pipeline-transmits-philosophical-architecture-not-guaranteed-wisdom.md",
|
||||
"issues": [
|
||||
"no_frontmatter"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 1,
|
||||
"kept": 0,
|
||||
"fixed": 1,
|
||||
"rejected": 1,
|
||||
"fixes_applied": [
|
||||
"fiction-to-reality-pipeline-transmits-philosophical-architecture-not-guaranteed-wisdom.md:set_created:2026-03-18"
|
||||
],
|
||||
"rejections": [
|
||||
"fiction-to-reality-pipeline-transmits-philosophical-architecture-not-guaranteed-wisdom.md:no_frontmatter"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -0,0 +1,37 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 7,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:set_created:2026-03-18",
|
||||
"cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:stripped_wiki_link:coding agents cannot take accountability for mistakes",
|
||||
"cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:stripped_wiki_link:coding-agents-cannot-take-accountability-for-mistakes-which-",
|
||||
"cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:stripped_wiki_link:AI-agents-as-personal-advocates-collapse-Coasean-transaction",
|
||||
"accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md:set_created:2026-03-18",
|
||||
"accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md:stripped_wiki_link:economic-forces-push-humans-out-of-every-cognitive-loop-wher",
|
||||
"accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md:stripped_wiki_link:adaptive-governance-outperforms-rigid-alignment-blueprints-b"
|
||||
],
|
||||
"rejections": [
|
||||
"cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:missing_attribution_extractor",
|
||||
"accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -0,0 +1,25 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "food-is-medicine-rcts-show-consistent-diet-quality-improvements-but-inconsistent-clinical-outcomes.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 1,
|
||||
"kept": 0,
|
||||
"fixed": 2,
|
||||
"rejected": 1,
|
||||
"fixes_applied": [
|
||||
"food-is-medicine-rcts-show-consistent-diet-quality-improvements-but-inconsistent-clinical-outcomes.md:set_created:2026-03-18",
|
||||
"food-is-medicine-rcts-show-consistent-diet-quality-improvements-but-inconsistent-clinical-outcomes.md:stripped_wiki_link:SDOH-interventions-show-strong-ROI-but-adoption-stalls-becau"
|
||||
],
|
||||
"rejections": [
|
||||
"food-is-medicine-rcts-show-consistent-diet-quality-improvements-but-inconsistent-clinical-outcomes.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -0,0 +1,25 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "glp-1-combined-with-structured-exercise-achieves-60-percent-better-weight-maintenance-than-medication-alone-after-discontinuation.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 1,
|
||||
"kept": 0,
|
||||
"fixed": 2,
|
||||
"rejected": 1,
|
||||
"fixes_applied": [
|
||||
"glp-1-combined-with-structured-exercise-achieves-60-percent-better-weight-maintenance-than-medication-alone-after-discontinuation.md:set_created:2026-03-18",
|
||||
"glp-1-combined-with-structured-exercise-achieves-60-percent-better-weight-maintenance-than-medication-alone-after-discontinuation.md:stripped_wiki_link:glp-1-persistence-drops-to-15-percent-at-two-years-for-non-d"
|
||||
],
|
||||
"rejections": [
|
||||
"glp-1-combined-with-structured-exercise-achieves-60-percent-better-weight-maintenance-than-medication-alone-after-discontinuation.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -7,10 +7,14 @@ date: 2015-00-00
|
|||
domain: entertainment
|
||||
secondary_domains: [grand-strategy]
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [fiction-to-reality-pipeline, survivorship-bias, star-trek, cell-phone, martin-cooper, disconfirmation, narrative-infrastructure, causation-vs-correlation]
|
||||
flagged_for_leo: ["The most-cited example of the fiction-to-reality pipeline is partially mythological — the narrative about narrative infrastructure was constructed post-hoc. This challenges the causal direction of Belief 1 and 2 across multiple domains."]
|
||||
processed_by: clay
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["worldbuilding-as-narrative-infrastructure-creates-communal-meaning-through-transmedia-coordination-of-audience-experience.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -73,3 +77,12 @@ Current confidence is "likely." This finding should move it closer to "experimen
|
|||
PRIMARY CONNECTION: [[narratives are infrastructure not just communication because they coordinate action at civilizational scale]]
|
||||
WHY ARCHIVED: Direct challenge to the most-cited evidence for the fiction-to-reality pipeline. Martin Cooper himself says the Star Trek story is not true. This is the survivorship bias problem instantiated in the canonical example.
|
||||
EXTRACTION HINT: This source should NOT generate a new claim — it should generate an update to the confidence level on narratives are infrastructure or the removal of Star Trek as the primary example in the beliefs.md grounding. Flag for Clay to review beliefs.md Belief 2 grounding.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Motorola began developing handheld cellular technology in the late 1950s, before Star Trek premiered in 1966
|
||||
- In 1967, Motorola released a handheld portable radio system for police departments
|
||||
- Martin Cooper invented the first handheld mobile phone in the early 1970s
|
||||
- The Motorola StarTAC flip phone was released in 1996
|
||||
- Martin Cooper appeared in the documentary 'How William Shatner Changed the World'
|
||||
- Dick Tracy's wrist watch communicator appeared in 1930s comic strips
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2018-00-00
|
|||
domain: entertainment
|
||||
secondary_domains: [grand-strategy]
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: null-result
|
||||
priority: medium
|
||||
tags: [fiction-to-reality-pipeline, foundation-asimov, spacex, musk, critical-analysis, survivorship-bias, narrative-infrastructure]
|
||||
processed_by: clay
|
||||
processed_date: 2026-03-18
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "LLM returned 1 claims, 1 rejected by validator"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -50,3 +54,10 @@ Literary critic Jonny Diamond argues that Elon Musk fundamentally misapplies Asi
|
|||
PRIMARY CONNECTION: the fiction-to-reality pipeline is real but probabilistic
|
||||
WHY ARCHIVED: Critical counter-perspective that accepts the pipeline's causal direction while questioning the quality of outcome. Adds important nuance: pipeline transmits influence, not wisdom.
|
||||
EXTRACTION HINT: Could yield a refinement or challenge to the pipeline claim — "pipeline shapes strategic mission but doesn't guarantee the mission is well-formed." Consider as evidence for the "probabilistic" qualifier in Belief 2.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Elon Musk cited Asimov's Foundation trilogy as influence for SpaceX in 2017 Rolling Stone interview
|
||||
- Musk stated his goal as 'take the set of actions that are likely to prolong civilization' and minimize dark ages
|
||||
- Jonny Diamond is Literary Hub's editor in chief
|
||||
- Article published circa 2018 after the 2017 Rolling Stone profile
|
||||
|
|
|
|||
|
|
@ -7,10 +7,14 @@ date: 2025-01-01
|
|||
domain: ai-alignment
|
||||
secondary_domains: [internet-finance]
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: null-result
|
||||
priority: medium
|
||||
tags: [agentbound-tokens, accountability, skin-in-the-game, cryptoeconomics, mechanism-design, AI-agents, governance]
|
||||
flagged_for_rio: ["Cryptoeconomic mechanism design for AI agent accountability — tiered staking, slashing, DAO governance. Rio should evaluate whether the staking mechanism has prediction market properties for surfacing AI reliability signals"]
|
||||
processed_by: theseus
|
||||
processed_date: 2026-03-18
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "LLM returned 2 claims, 2 rejected by validator"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -63,3 +67,12 @@ PRIMARY CONNECTION: [[coding agents cannot take accountability for mistakes whic
|
|||
WHY ARCHIVED: First governance mechanism specifically designed for AI agent accountability using cryptoeconomic principles. Also relevant to Rio's mechanism design territory.
|
||||
|
||||
EXTRACTION HINT: Focus on the accountability-scales-with-autonomy principle and the staking model structure. Note the key limitation: measurement dependency. Do not over-claim — this is a working paper with no deployment evidence.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Agentbound Tokens (ABTs) are cryptographic tokens serving as 'tamper-proof digital birth certificates' for autonomous AI agents
|
||||
- ABT mechanism includes temporary blacklisting for repeat offenses
|
||||
- ABT validator DAOs use hybrid human-AI oversight
|
||||
- ABT governance uses utility-weighted voting where power derives from task success rates and energy efficiency
|
||||
- ABT governance includes per-agent caps to prevent monopolization
|
||||
- Working paper authored by Tomer Jordi Chaffer at McGill University with contributions from Goldston, Muttoni, Zhao, Shaw Walters
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2025-01-01
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: systematic-review
|
||||
status: unprocessed
|
||||
status: null-result
|
||||
priority: high
|
||||
tags: [food-is-medicine, systematic-review, rct, hba1c, blood-pressure, bmi, aha, clinical-outcomes, evidence-review]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-18
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "LLM returned 1 claims, 1 rejected by validator"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -63,3 +67,13 @@ AHA Scientific Statement published in Circulation reviewing 14 US randomized con
|
|||
PRIMARY CONNECTION: Existing food-as-medicine / SDOH evidence claims in health domain
|
||||
WHY ARCHIVED: Most authoritative US RCT evidence review on FIM clinical outcomes — the canonical source for "what the evidence actually says"
|
||||
EXTRACTION HINT: Extract two claims: (1) FIM consistently improves diet quality and food security (proven); (2) FIM clinical outcomes (HbA1c, BP, BMI) are inconsistent and often non-significant in RCTs (likely). These are different claims that the field conflates.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- AHA Scientific Statement reviewed 14 US randomized controlled trials of Food Is Medicine interventions
|
||||
- FIM intervention types reviewed: medically tailored meals, produce prescriptions, medically tailored groceries, food pharmacies
|
||||
- Clinical outcomes assessed: HbA1c, blood pressure, BMI
|
||||
- Medically tailored meals have the most evidence and highest intervention specificity among FIM types
|
||||
- AHA supports expansion and standardization of FIM programs despite inconsistent RCT evidence
|
||||
- Recipe4Health observational study (2,643 participants) showed HbA1c -0.37%, non-HDL -17 mg/dL but was not an RCT
|
||||
- Multisite evaluation of 9 produce prescription programs showed improvements in food security and F&V intake but was not RCT design
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2026-03-01
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: review
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [glp-1, lifestyle-modification, exercise, sarcopenia, muscle-preservation, adherence, weight-regain, obesity]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics.md", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -75,3 +79,12 @@ Synthesis of 2025-2026 research on combining lifestyle modifications (diet, exer
|
|||
PRIMARY CONNECTION: GLP-1 cost-effectiveness under capitation requires solving the adherence paradox (March 12 claim candidate)
|
||||
WHY ARCHIVED: The "exercise is the active ingredient for weight maintenance" finding significantly changes how to evaluate BALANCE model design and GLP-1 economic models under VBC
|
||||
EXTRACTION HINT: Focus on the GLP-1 alone vs. GLP-1+exercise regain comparison — this is the claim-worthy finding. Also note the BALANCE model design needs evaluation against this evidence.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- WHO December 2025 guidelines recommend GLP-1 therapies 'combined with intensive behavioral therapy to maximize and sustain benefits'
|
||||
- Meta-analysis of 22 RCTs with 2,258 participants found ~25% of GLP-1 weight loss is lean mass
|
||||
- Without exercise, 15-40% of GLP-1 weight loss is lean mass; with resistance training, lean mass loss is substantially reduced
|
||||
- Up to 50% of adults over 80 experience sarcopenia; aging reduces muscle mass 12-16% independent of weight loss interventions
|
||||
- Tirzepatide may have better muscle preservation profile than semaglutide (preliminary data, not FDA-approved for this indication)
|
||||
- BALANCE model includes lifestyle support component but specific exercise programming details not specified in source
|
||||
|
|
|
|||
Loading…
Reference in a new issue